arsenic trisulfide has been researched along with Granulocytic Leukemia, Chronic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Q; Chen, SJ; Chen, Z; Huang, QH; Liu, P; Lu, J; Mao, JH; Weng, L; Xie, YY; Zhang, QY; Zhang, Y | 1 |
| Chen, Q; Chen, SJ; Chen, Z; Huang, QH; Li, KK; Liu, JX; Liu, P; Mao, JH; Sun, XY; Zhang, QY | 1 |
| Chen, GQ; Chen, SJ; Chen, Z; Du, YZ; Sun, GL; Sun, HP; Wang, KK; Wu, YL; Yin, T; Zhang, J | 1 |
3 other study(ies) available for arsenic trisulfide and Granulocytic Leukemia, Chronic
| Article | Year |
|---|---|
A systems biology understanding of the synergistic effects of arsenic sulfide and Imatinib in BCR/ABL-associated leukemia.
Topics: Animals; Arsenicals; Benzamides; Cell Line, Tumor; Disease Models, Animal; Drug Synergism; Fusion Proteins, bcr-abl; Gene Expression Profiling; Gene Expression Regulation, Leukemic; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mice; Models, Molecular; Neoplasm Transplantation; Phosphatidylinositol 3-Kinases; Piperazines; Proteasome Endopeptidase Complex; Protein Kinases; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Pyrimidines; Signal Transduction; Sulfides; Survival Rate; Systems Biology; TOR Serine-Threonine Kinases; Ubiquitins | 2009 |
As4S4 targets RING-type E3 ligase c-CBL to induce degradation of BCR-ABL in chronic myelogenous leukemia.
Topics: Amino Acid Sequence; Animals; Arsenicals; Fusion Proteins, bcr-abl; HeLa Cells; Humans; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mice; Models, Molecular; Molecular Sequence Data; Multiprotein Complexes; Protein Conformation; Proto-Oncogene Proteins c-cbl; Random Allocation; Sulfides; Ubiquitination | 2010 |
Combined effects of As4S4 and imatinib on chronic myeloid leukemia cells and BCR-ABL oncoprotein.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Arsenicals; Benzamides; Cell Line, Tumor; Cell Survival; DNA, Neoplasm; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Piperazines; Pyrimidines; Sulfides | 2004 |